tiprankstipranks
MIRA Pharmaceuticals, Inc. (MIRA)
:MIRA
US Market

MIRA Pharmaceuticals, Inc. (MIRA) Income Statement

Compare
207 Followers

MIRA Pharmaceuticals, Inc. Income Statement

Last quarter (Q3 2024), MIRA Pharmaceuticals, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, MIRA Pharmaceuticals, Inc.'s net income was $-2.04M. See MIRA Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -8.53M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 8.53M$ 7.05M$ 2.15M$ 67.63K
Depreciation and Amortization
$ 8.53M$ 7.05M$ 2.15M$ 202.89K
EBITDA
$ 0.00$ -7.05M$ -2.15M$ 0.00
Operating Income
$ -8.53M$ -7.05M$ -2.15M$ -67.63K
Other Income/Expenses
$ -3.46M$ -10.25K$ -24.37K$ 134.89K
Pretax Income
$ -11.98M$ -7.06M$ -2.18M$ -67.99K
Net Income
$ -11.98M$ -7.06M$ -2.18M$ -67.99K
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -0.65$ -0.48$ -0.15$ 0.00
Diluted EPS
$ -0.65$ -0.48$ -0.15$ 0.00
Weighted Average Shares Outstanding
18.57M 14.75M 14.75M 14.75M
Weighted Average Shares Outstanding (Diluted)
18.57M 14.75M 14.75M 14.75M
Currency in USD

MIRA Pharmaceuticals, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis